BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22111813)

  • 21. Gender-dependent variations in systemic biomarkers of oxidative protein, DNA, and lipid damage in aged rats.
    Cakatay U; Aydin S; Yanar K; Uzun H
    Aging Male; 2010 Mar; 13(1):51-8. PubMed ID: 19883294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study on the effects of almond consumption on DNA damage and oxidative stress in smokers.
    Jia X; Li N; Zhang W; Zhang X; Lapsley K; Huang G; Blumberg J; Ma G; Chen J
    Nutr Cancer; 2006; 54(2):179-83. PubMed ID: 16898862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma.
    Dincer Y; Himmetoglu S; Akcay T; Ersoy EY; Gunes KN; Tortum O
    Neoplasma; 2007; 54(2):131-6. PubMed ID: 17319786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of 8-oxo-7, 8-dihydro-2'-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer.
    Peddireddy V; Siva Prasad B; Gundimeda SD; Penagaluru PR; Mundluru HP
    Biomarkers; 2012 May; 17(3):261-8. PubMed ID: 22397584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.
    Turkmen K; Tonbul HZ; Toker A; Gaipov A; Erdur FM; Cicekler H; Anil M; Ozbek O; Selcuk NY; Yeksan M; Turk S
    Ren Fail; 2012; 34(10):1229-37. PubMed ID: 23025491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.
    Ahmadpoor P; Eftekhar E; Nourooz-Zadeh J; Servat H; Makhdoomi K; Ghafari A
    Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus.
    Pácal L; Varvařovská J; Rušavý Z; Lacigová S; Stětina R; Racek J; Pomahačová R; Tanhäuserová V; Kaňková K
    Arch Physiol Biochem; 2011 Oct; 117(4):222-30. PubMed ID: 21338322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
    Müller C; Eisenbrand G; Gradinger M; Rath T; Albert FW; Vienken J; Singh R; Farmer PB; Stockis JP; Janzowski C
    Free Radic Res; 2004 Oct; 38(10):1093-100. PubMed ID: 15512797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a hemodiafiltration session with on-line regeneration of the ultrafiltrate on oxidative stress. Comparative study with conventional hemodialysis with polysulfone.
    González-Diez B; Cavia M; Torres G; Abaigar P; Muñiz P
    Blood Purif; 2008; 26(6):505-10. PubMed ID: 18931477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
    Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
    Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
    Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
    Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
    Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
    Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysis type may predict carotid intima media thickness and plaque presence in end-stage renal disease patients.
    Mutluay R; Degertekin CK; Poyraz F; Yılmaz MI; Yücel C; Turfan M; Tavil Y; Derici Ü; Arınsoy T; Sindel S
    Adv Ther; 2012 Apr; 29(4):370-82. PubMed ID: 22467434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M; Kirkpantur A; Gulbay M; Gurbuz OA
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.